Borisov Se

Top papers

• Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis

  Francesca Conradie, Tatevik R. Bagdasaryan, Borisov Se, et al.·2022·New England Journal of Medicine
  ↗ 544OA
• Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases

  Marina Tadolini, Luigi Ruffo Codecasa, José-María García-García, et al.·2020·European Respiratory Journal
  ↗ 402OA
• Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

  Borisov Se, Keertan Dheda, Martin Enwerem, et al.·2017·European Respiratory Journal
  ↗ 300OA
• MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

  Giovanni Battista Migliori, Simon Tiberi, Alimuddin Zumla, et al.·2020·International Journal of Infectious Diseases
  ↗ 224OA
• Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020

  Giovanni Battista Migliori, Pei Min Thong, Onno W. Akkerman, et al.·2020·Emerging infectious diseases
  ↗ 222OA
• Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

  Borisov Se, Edvardas Danila, Andrei Maryandyshev, et al.·2019·European Respiratory Journal
  ↗ 174OA
• Clinical standards for the assessment, management and rehabilitation of post-TB lung disease

  Giovanni Battista Migliori, Florian M. Marx, Nicolino Ambrosino, et al.·2021·The International Journal of Tuberculosis and Lung Disease
  ↗ 171OA
• Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region

  Danila Zimenkov, E. Yu. Nosova, Elena V. Kulagina, et al.·2017·Journal of Antimicrobial Chemotherapy
  ↗ 140OA
• On tuberculosis and COVID-19 co-infection

  Marina Tadolini, José-María García-García, F.–X. Blanc, et al.·2020·European Respiratory Journal
  ↗ 132OA
• Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions.

  Wieslaw Jakubowiak, E. M. Bogorodskaya, Borisov Se, et al.·2007·PubMed
  ↗ 132
• INCIDENCE, MORTALITY AND PREVALENCE AS INDICATORS OF TUBERCULOSIS BURDEN IN WHO REGIONS , COUN TRIES OF THE WORLD AND THE RUSSIAN FEDERATION. Part 2. Tuberculosis mortality

  I. A. Vasilyeva, E. M. Belilovsky, Borisov Se, et al.·2017·Tuberculosis and lung diseases
  ↗ 66OA
• Reduced susceptibility and resistance to bedaquiline in clinical M. tuberculosis isolates

  I. V. Peretokina, L. Yu. Krylova, О. В. Антонова, et al.·2020·Journal of Infection
  ↗ 62